Regulatory Measures Could Mitigate EU Coronavirus Risks
Medicines For Europe Sets Out Potential Solutions To COVID-19 Impact
Executive Summary
As part of its response to the coronavirus outbreak, Medicines for Europe has set out a series of policy recommendations that it says could help to mitigate the risks of COVID-19.
You may also be interested in...
EU Must Plan For Demand Spikes Amid Coronavirus
Stakeholders across the European medicines industry must co-ordinate to plan for increases in demand as the region continues to grapple with the coronavirus outbreak, off-patent industry association Medicines for Europe has insisted.
Three Key EU Actions Needed On Coronavirus
Immediate EU-wide measures are needed to ensure the supply of medicines, according to off-patent industry association Medicines for Europe, which has also called for clear regulatory guidance and scenario planning to address the challenges posed by the coronavirus outbreak.
European Coronavirus Planning Requires ‘Structured Dialog’
European off-patent industry association Medicines for Europe has called on the European Commission to urgently establish a “structured dialog” involving industry stakeholders, to help plan for an extended outbreak of coronavirus.